Chemoinformaics analysis of 4-Hydroxy-Alpha-Lapachone
| Molecular Weight | 258.273 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 17 |
| Exact Molecular Weight | 258.089 | nRing | 3 |
| Solubility: LogS | -3.909 | nHRing | 1 |
| Solubility: LogP | 3.649 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 37.5931 |
| nHD | 1 | BPOL | 17.5169 |
| QED | 0.713 |
| Synth | 2.576 |
| Natural Product Likeliness | 1.145 |
| NR-PPAR-gamma | 0.964 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.025 |
| Pgp-sub | 0 |
| HIA | 0.012 |
| CACO-2 | -4.84 |
| MDCK | 0.0000313 |
| BBB | 0.055 |
| PPB | 0.977432 |
| VDSS | 0.548 |
| FU | 0.0228004 |
| CYP1A2-inh | 0.929 |
| CYP1A2-sub | 0.541 |
| CYP2c19-inh | 0.441 |
| CYP2c19-sub | 0.296 |
| CYP2c9-inh | 0.631 |
| CYP2c9-sub | 0.793 |
| CYP2d6-inh | 0.456 |
| CYP2d6-sub | 0.334 |
| CYP3a4-inh | 0.182 |
| CYP3a4-sub | 0.17 |
| CL | 4.663 |
| T12 | 0.336 |
| hERG | 0.006 |
| Ames | 0.186 |
| ROA | 0.472 |
| SkinSen | 0.825 |
| Carcinogencity | 0.709 |
| EI | 0.489 |
| Respiratory | 0.369 |
| NR-Aromatase | 0.379 |
| Antiviral | No |
| Prediction | 0.59434 |